Teva
Teva returns laquinimod global rights to Active Biotech
Teva Pharmaceutical Industries has returned global development and commercialisation rights to drug candidate laquinimod to Swedish biotechnology company Active Biotech.…
Fasinumab Phase III osteoarthritis trial meets endpoints
Teva Pharmaceutical and Regeneron Pharmaceuticals have reported positive top-line data from a phase III clinical trial of fasinumab to treat…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox